Share This

Public company info - Wuhan YZY Biopharma Co. Ltd. - H Shares , 02496.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Wuhan YZY Biopharma Co. Ltd. - H Shares, 02496.HK - Cash Flow 2022-12 2021-12
Net Cash Flow from Operating Activities -176,703 -98,710
Net Cash Flow from Return on Investments & Servicing of Finance -2,185 -3,836
 Interest Received 283 162
 Interest Paid -2,468 -3,998
 Dividend Received 0 0
 Dividend Paid 0 0
 Others 0 0
Taxes (Paid) / Refunded 0 0
Net Cash Flow from Investing Activities 5,521 -20,095
 Additions to Fixed Assets -1,411 -1,903
 Disposal of Fixed Assets 0 47
 Increase in Investments -378,500 -481,600
 Decrease in Investments 351,000 462,100
 Net Cash Flow with Related Parties 0 -71,070
 Others 34,432 72,331
Net Cash Flow before Financing Activities -173,367 -122,641
Net Cash Flow from Financing Activities 243,802 85,032
 New Loans 76,500 28,000
 Loans Repayment -28,436 -21,411
 Fixed Income/Debt Instruments 0 0
 Repayment of Fixed Income/Debt Instruments 0 0
 Equity Financing 200,000 149,910
 Net Cash Flow with Related Parties 0 -71,070
 Others -4,262 -397
Increase(Decrease) in Cash & Cash Equivalents 70,435 -37,609
Cash & Cash Equivalents at Beginning of Year 83,085 120,694
Net Cash Flow due to Change in Exchange Rate/Others 0 0
Cash & Cash Equivalents at End of Year 153,520 83,085
Currency Renminbi Renminbi
Unit
Auditor's Opinion 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.